-5%
Ebasten 10 mg is indicated for the symptomatic treatment of: Seasonal and Perennial Allergic Rhinitis. Chronic Idiopathic Urticaria.
Ebasten 10 mg is a long-acting and selective H1-histamine receptor antagonist. After repeated administration, inhibition of peripheral receptors remains at a constant level. Ebasten 10 mg is rapidly absorbed and undergoes extensive first-pass metabolism following oral administration. Ebasten 10 mg is almost totally converted to the pharmacologically active acid metabolite, carEbasten 10 mg.
Ebasten 10 mg, a piperidine derivative, is a long-acting, nonsedating, second-generation histamine receptor antagonist that binds preferentially to peripheral H1 receptors. It is metabolised to the active metabolite, carEbasten 10 mg. It has antihistaminic, antiallergic activity and prevents histamine-induced bronchoconstriction. It does not have significant sedative or antimuscarinic actions.